PCVX Vaxcyte Inc

Price (delayed)

$56.495

Market cap

$8.41B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$7.63

Enterprise value

$8.34B

?
Relative Growth: Rel. Growth: 1
Relative Strength: Rel. Strength: 77
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 5
Highlights
The net income has plunged by 94% YoY and by 12% from the previous quarter
The EPS has plunged by 86% YoY and by 11% from the previous quarter

Key stats

What are the main financial stats of PCVX

PCVX stock price

How has the Vaxcyte stock price performed over time
Intraday
-4.28%
1 week
-3.87%
1 month
-9.78%
1 year
70.42%
YTD
22.44%
QTD
-2.81%

Financial performance

How have Vaxcyte's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$1.17B
Net income
-$1.06B
Gross margin
N/A
Net margin
N/A
The net income has plunged by 94% YoY and by 12% from the previous quarter
Vaxcyte's operating income has shrunk by 64% YoY and by 7% QoQ

Price vs fundamentals

How does PCVX's price correlate with its fundamentals

Growth

What is Vaxcyte's growth rate over time

Valuation

What is Vaxcyte stock price valuation
P/E
N/A
P/B
2.96
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has plunged by 86% YoY and by 11% from the previous quarter
The P/B is 29% higher than the last 4 quarters average of 2.4 but 6% lower than the 5-year quarterly average of 3.3
Vaxcyte's equity has decreased by 10% YoY and by 8% QoQ

Efficiency

How efficient is Vaxcyte business performance
Vaxcyte's return on equity has shrunk by 122% YoY and by 16% QoQ
PCVX's ROA has shrunk by 111% YoY and by 14% QoQ
PCVX's ROIC has dropped by 97% year-on-year and by 14% since the previous quarter

Dividends

What is PCVX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PCVX.

Financial health

How did Vaxcyte financials performed over time
The total liabilities has surged by 62% year-on-year and by 8% since the previous quarter
PCVX's quick ratio is down by 49% year-on-year and by 24% since the previous quarter
The debt is 96% smaller than the equity
The debt is up by 34% year-on-year
The company's debt to equity rose by 33% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.